Articolul precedent |
Articolul urmator |
![]() |
![]() ![]() |
![]() GALESCU, Andrei, SAJIN, Octavian, SPÎNU, Constantin, ISAC, Maria, BLAJ, Valentina, IZIUMOV, Nina, SPÎNU, Igor, IVANOV (LITOVCENCO), Mihaela, VALISIEV, Vladislav, CEBAN, Emil. Serologic status prevalence of viral hepatitis a, b, c, and e markers at urology healthcare workers. In: New horizons in urology: The 8th congress on urology, dialysis and kidney transplant from Republic of Moldova with international participation, 7-9 iunie 2023, Chişinău. Chişinău: Taicom (Ridgeone Group), 2023, p. 387. ISSN 2558-815X. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
New horizons in urology 2023 | ||||||
Conferința "New horizons in urology" Chişinău, Moldova, 7-9 iunie 2023 | ||||||
|
||||||
Pag. 387-387 | ||||||
|
||||||
![]() |
||||||
Rezumat | ||||||
Objectives. To determine the seroprevalence level of viral hepatitis markers A, B, C, and E among urological healthcare from department of Republican Clinical Hospital. Methods. A crosssectional descriptive epidemiological study was conducted. Blood samples were collected from medical workers and examined using the enzymelinked immunosorbent assay (ELISA) method for markers of viral hepatitis A (anti-HAV and anti-HAV IgM), viral hepatitis B (AgHBs, antiHBcor, anti-HBs), viral hepatitis C (anti-HCV), and viral hepatitis E (anti-HEV IgG and antiHEV IgM). A total of 49 medical workers were examined, and 392 laboratory investigations were performed. Results. The following seroprevalence levels of viral markers were identified among urology healthcare: AgHBs–2.0±2.0%; antiHBcor–38.8±7.0%; anti-HBs–51.0±7.1%; antiHCV– 4.1±2.8%; anti-HAV–100%; anti-HAV IgM–0%; anti-HEV IgG–12.2±4.7%; anti-HEV IgM– 12.2±4.7%. The most affected groups were female individuals, medical assistants or auxiliary personnel, and with a work experience of ≥30 years. Conclusions. The results indicate that medical workers in the field of urology can be considered a high-risk group for infection with hepatitis B, C, and E viruses. |
||||||
|
DataCite XML Export
<?xml version='1.0' encoding='utf-8'?> <resource xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xmlns='http://datacite.org/schema/kernel-3' xsi:schemaLocation='http://datacite.org/schema/kernel-3 http://schema.datacite.org/meta/kernel-3/metadata.xsd'> <creators> <creator> <creatorName>Galescu, A.V.</creatorName> <affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Sajin, O.G.</creatorName> <affiliation>Agenţia Naţională pentru Sănătate Publică, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Spînu, C.I.</creatorName> <affiliation>Agenţia Naţională pentru Sănătate Publică, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Isac, M.</creatorName> <affiliation>Agenţia Naţională pentru Sănătate Publică, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Blaj, V.</creatorName> <affiliation>Agenţia Naţională pentru Sănătate Publică, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Iziumov, N.</creatorName> <affiliation>Agenţia Naţională pentru Sănătate Publică, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Spînu, I.</creatorName> <affiliation>Agenţia Naţională pentru Sănătate Publică, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Ivanov (Litovcenco), M.A.</creatorName> <affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Valisiev, V.</creatorName> <affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Ceban, E.D.</creatorName> <affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation> </creator> </creators> <titles> <title xml:lang='en'>Serologic status prevalence of viral hepatitis a, b, c, and e markers at urology healthcare workers</title> </titles> <publisher>Instrumentul Bibliometric National</publisher> <publicationYear>2023</publicationYear> <relatedIdentifier relatedIdentifierType='ISBN' relationType='IsPartOf'></relatedIdentifier> <dates> <date dateType='Issued'>2023</date> </dates> <resourceType resourceTypeGeneral='Text'>Conference Paper</resourceType> <descriptions> <description xml:lang='en' descriptionType='Abstract'><p>Objectives. To determine the seroprevalence level of viral hepatitis markers A, B, C, and E among urological healthcare from department of Republican Clinical Hospital. Methods. A crosssectional descriptive epidemiological study was conducted. Blood samples were collected from medical workers and examined using the enzymelinked immunosorbent assay (ELISA) method for markers of viral hepatitis A (anti-HAV and anti-HAV IgM), viral hepatitis B (AgHBs, antiHBcor, anti-HBs), viral hepatitis C (anti-HCV), and viral hepatitis E (anti-HEV IgG and antiHEV IgM). A total of 49 medical workers were examined, and 392 laboratory investigations were performed. Results. The following seroprevalence levels of viral markers were identified among urology healthcare: AgHBs–2.0±2.0%; antiHBcor–38.8±7.0%; anti-HBs–51.0±7.1%; antiHCV– 4.1±2.8%; anti-HAV–100%; anti-HAV IgM–0%; anti-HEV IgG–12.2±4.7%; anti-HEV IgM– 12.2±4.7%. The most affected groups were female individuals, medical assistants or auxiliary personnel, and with a work experience of ≥30 years. Conclusions. The results indicate that medical workers in the field of urology can be considered a high-risk group for infection with hepatitis B, C, and E viruses.</p></description> </descriptions> <formats> <format>application/pdf</format> </formats> </resource>